MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by lalala1on Feb 29, 2008 1:00pm

158 Views

Post# 14574437

RE: BNN Interview

Thank you for that. I agree based on that post and the timing of the BNN interview, it is looking like the 1st or second week of March for the Q2. which would be a little later than the past couple of years but not super late. And I also agree it seems like they are quite eager to release these results. Although I'm not willing to predict they are turning a profit I feel safe in saying this will probably be one of their best quarters yet... or at least in quite a long while.

Bullboard Posts

TELUS adds 347K customers in Q3